Home

Adaptive Biotechnologies Corporation - Common Stock (ADPT)

11.69
+0.64 (5.79%)
NASDAQ · Last Trade: Aug 6th, 6:33 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Adaptive (ADPT) Q2 Revenue Surges 36%fool.com
Via The Motley Fool · August 6, 2025
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · August 5, 2025
Earnings Scheduled For August 5, 2025benzinga.com
Via Benzinga · August 5, 2025
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeuticsbenzinga.com
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
Via Benzinga · July 26, 2025
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internetbenzinga.com
Via Benzinga · June 21, 2025
Earnings Scheduled For May 1, 2025benzinga.com
Via Benzinga · May 1, 2025
Assessing Adaptive Biotechnologies: Insights From 5 Financial Analystsbenzinga.com
Via Benzinga · June 18, 2025
ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A High-Growth Stock Meeting Minervini’s Trend Templatechartmill.com
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a compelling candidate for momentum investors.
Via Chartmill · June 14, 2025
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administrationbenzinga.com
Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.
Via Benzinga · May 30, 2025
ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A Strong Growth Candidate Meeting Minervini’s Criteriachartmill.com
ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a candidate for growth investors. The stock scores a perfect 10 on technical health but may need consolidation before an optimal entry.
Via Chartmill · May 13, 2025
5 Analysts Assess Adaptive Biotechnologies: What You Need To Knowbenzinga.com
Via Benzinga · May 5, 2025
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Resultsbenzinga.com
Via Benzinga · May 2, 2025
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · May 2, 2025
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · May 2, 2025
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbsbenzinga.com
On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.
Via Benzinga · April 23, 2025
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 22, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 16, 2025
Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 4, 2025
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · April 4, 2025
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · April 2, 2025
Analyst Expectations For Adaptive Biotechnologies's Futurebenzinga.com
Via Benzinga · March 21, 2025
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Fridaybenzinga.com
Via Benzinga · March 21, 2025
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzledtalkmarkets.com
Small caps took another step down this past week as geopolitical events dampened sentiment.
Via Talk Markets · March 10, 2025
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologiesbenzinga.com
Via Benzinga · February 22, 2025
Earnings Scheduled For February 11, 2025benzinga.com
Via Benzinga · February 11, 2025